ANN ARBOR ? Biopharmaceutcal company NanoBio has hired a new executive, Stephen Gracon, D.V.M., as vice president of regulatory affairs. Dr. Gracon will lead the regulatory and quality assurance activities for the company's pipeline of anti-infective products and mucosal vaccines. Dr. Gracon brings 30 years of experience to NanoBio in diverse areas within the pharmaceutical
GRAND RAPIDS - The Van Andel Research Institute has named James Fahner, M.D., the current and founding division chief of pediatric hematology and oncology and senior administrative physician for philanthropy and community relations at Helen DeVos Children?s Hospital, to its Board of Trustees. Dr. Fahner was elected in December 2007 by the three members of
KALAMAZOO - The Southwest Michigan Innovation Center and MichBio have teamed up to offer a quarterly series of networking and educational events for life sciences companies in southwest Michigan. The first event is scheduled for Jan. 15 at the Southwest Michigan Innovation Center. The first event, ?Life Outside the Incubator? will feature a panel of
GRAND RAPIDS - The Center for Molecular Medicine announced it is one of the first laboratories in the nation to offer a new test to help guide the treatment of metastatic colorectal cancer. The CMM is offering the CellSearch System from Veridex to physicians as a vital new tool in managing patients with metastatic CRC.
DETROIT ? The U.S.-Dutch Mass Spectrometry Consortium for advanced biological structure and imaging applications, led by Wayne State University Professor Mary Rodgers, has been awarded a $2.5 million grant from the National Science Foundation. This five-year grant is a unique multicultural collaboration, which includes ten U.S. researchers from nine universities and researchers from two Netherlands-based
LANSING - As opponents to Michigan's 1996 law granting broad-based immunity to drug manufacturers continue efforts to win passage of HB 4044 , HB 4045 and HB 4046 in the Senate, the chair of the Senate Judiciary Committee said Monday he did not see any conditions right now under which he would hold hearings on
MADISON, Wis. - In the quest to treat difficult diseases, researchers have created human embryonic stem cells without destroying embryos or using hard-to-get eggs. The technique may prove to be easier, cheaper, and more ethically appealing than an alternative approach that requires cloning. Two separate teams of researchers say they have sidestepped the cloning method
LANSING - The Michigan House Judiciary Committee discussed legislation allowing individuals using in vitro fertilization the option of donating their unused embryos for stem cell research while also increasing the penalties for human cloning, but most of those who testified over the course of nearly five hours voiced their opposition to or support for the
CLEVELAND - Midwest health care startups reported a record-breaking $1 billion in total investments for 104 companies through the third quarter of 2007, according to the BioEnterprise Midwest Health Care Venture Investment Report. The previous full-year record for Midwest health care companies was $783 million in 2006. Ohio and Minnesota led all Midwestern states in
ANN ARBOR - NanoBio Corporation, a biopharmaceutical company, announced Tuesday it has hired Joyce Sutcliffe, Ph.D., as vice president of research. She previously was chief research scientist for Rib-X Pharmaceuticals. Sutcliffe brings 26 years of experience in the discovery and design of new antibiotics, with particular emphasis on understanding and overcoming antibiotic resistance. During her